Business
Concepta to supply myLotus® to Boots UK
Concepta to supply myLotus® to Boots UK.
About this update from Fortis Frontier Plc
[{"type":"text","content":"\n \nRNS Number : 3750U Concepta PLC 29 March 2019 \n\n \n \nConcepta to supply myLotus® to Boots UK \n \nConcepta Plc (AIM: CPT), the innovative UK personalised healthcare company and developer of the proprietary self-test platform (\"myLotus®\") and suite of emerging test products targeting the mobile health market, is pleased to announce it has agreed to supply the myLotus® product for women's fertility and hormone testing to Boots UK, a member of Walgreens Boots Alliance. \nmyLotus® the revolutionary home based, self-test product was launched in November 2018 with early 'trying to conceive' users providing personal video feedback and testimonials on their menstrual cycle hormone changes and hormone patterns ('signatures') enabling women to better understand their menstrual cycle and fertility journey (www.mylotus.com).\nThe Boots supply agreement represents the first commercial partnership forming part of the Company's EU roll-out plans. myLotus® recently received CE-Mark certification and the agreement allows the Company to sell its product online at www.Boots.com as well as to other partners across EU markets (CE-Mark territories). \nmyLotus® empowers women to self-test their personalised hormone levels and identify their optimal fertile days thereby improving their chances of naturally getting pregnant. myLotus® enables women to monitor their fertile phase as part of their menstrual cycle and is the only home test to 'quantitatively' measure hormone levels and the 'rate-of-change' of these levels preceding ovulation to help aid a natural conception. Users measure, record and track their hormone levels and follow their fertility journey in an accompanying free downloadable app available in iOS and Android formats via the www.mylotus.com website.\nmyLotus® is available to women who are planning to start a family or for those who have previously struggled to naturally conceive, enabling couples an alternative prior to considering more costly IVF treatment. The Company expects to release further hormone health and wellbeing tests to complement its fertility offering later this year. \nMatthew Walls, Chairman said: \"We are delighted to work with such a respected British high-street b...